Skip to content 
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified. more
| Time Frame | CANC | S&P500 |
|---|---|---|
| 1-Week Return | 1.08% | -2.26% |
| 1-Month Return | -1.44% | -0.27% |
| 3-Month Return | -1.57% | 8.83% |
| 6-Month Return | 6.54% | 7.2% |
| 1-Year Return | 41.6% | 22.24% |
| 3-Year Return | 910.65% | 69.99% |
| Stock name | Ticker | Weight |
|---|---|---|
 REVOLUTION MEDICINES INC | RVMD | 6.59% |
 ELI LILLY & CO | LLY | 5.29% |
 LEGEND BIOTECH CORP | LEGN | 4.49% |
 NOVARTIS AG | NOVN.SW | 4.28% |
 ROCHE HOLDING AG | RHHBY | 4.25% |
 COGENT BIOSCIENCES INC | COGT | 4.23% |
 MERCK & CO INC | MRK | 3.71% |
 IMMUNOME INC | IMNM | 3.62% |
 BRISTOL-MYERS SQUIBB CO | BMY | 3.55% |
 ASTRAZENECA PLC | AZN.L | 3.29% |
 ABBVIE INC | ABBV | 2.97% |
 EXELIXIS INC | EXEL | 2.96% |
 NUVALENT INC | NUVL | 2.94% |
 BRIDGEBIO PHARMA INC | BBIO | 2.87% |
 JOHNSON & JOHNSON | JNJ | 2.64% |
 CELCUITY INC | CELC | 2.35% |
 IDEAYA BIOSCIENCES INC | IDYA | 2.31% |
 GENMAB A/S | GMAB | 2.29% |
 CG ONCOLOGY INC | CGON | 2.24% |
 AMGEN INC | AMGN | 2.22% |
 BEONE MEDICINES LTD | ONC | 1.87% |
 ZAI LAB LTD | ZLAB | 1.75% |
 ZYMEWORKS INC | ZYME | 1.54% |
 RELAY THERAPEUTICS INC | RLAY | 1.36% |
 HALOZYME THERAPEUTICS INC | HALO | 1.36% |
 CASH & CASH EQUIVALENTS | . | 1.3% |
 ENLIVEN THERAPEUTICS INC | ELVN | 1.2% |
 ARCUS BIOSCIENCES INC | RCUS | 1.2% |
 NUVATION BIO INC | NUVB | 1.19% |
 ERASCA INC | ERAS | 1.14% |
 GILEAD SCIENCES INC | GILD | 1.1% |
 ARRIVENT BIOPHARMA INC | AVBP | 1.1% |
 SUMMIT THERAPEUTICS INC | SMMT | 1.05% |
 IMMATICS NV | IMTX | 1.02% |
 ANAPTYSBIO INC | ANAB | 0.94% |
 UROGEN PHARMA LTD | URGN | 0.94% |
 CORVUS PHARMACEUTICALS INC | CRVS | 0.93% |
 GUARDANT HEALTH INC | GH | 0.85% |
 REGENERON PHARMACEUTICALS INC | REGN | 0.78% |
 SYNDAX PHARMACEUTICALS INC | SNDX | 0.76% |
 IOVANCE BIOTHERAPEUTICS INC | IOVA | 0.71% |
 CHUGAI PHARMACEUTICAL CO LTD | 4519.T | 0.65% |
 NATERA INC | NTRA | 0.55% |
 INHIBRX BIOSCIENCES INC | INBX | 0.54% |
 CULLINAN THERAPEUTICS INC | CGEM | 0.53% |
 IMMUNOCORE HOLDINGS PLC | IMCR | 0.52% |
 OLEMA PHARMACEUTICALS INC | OLMA | 0.5% |
 TYRA BIOSCIENCES INC | TYRA | 0.47% |
 BRIDGEBIO ONCOLOGY THERAPEUTICS INC | BBOT | 0.45% |
 CYTOMX THERAPEUTICS INC | CTMX | 0.42% |
 JANUX THERAPEUTICS INC | JANX | 0.41% |
 ARVINAS INC | ARVN | 0.38% |
 FIRST TRACKS BIOTHERAPEUTICS INC | TRAX | 0.33% |
 REPLIMUNE GROUP INC | REPL | 0.29% |
 ADLAI NORTYE LTD | ANL | 0.28% |
 ORIC PHARMACEUTICALS INC | ORIC | 0.27% |
 SELLAS LIFE SCIENCES GROUP INC | SLS | 0.21% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
Tema Oncology ETF (CANC) share price today is $36.474.
Yes, Indians can buy shares of Tema Oncology ETF (CANC) on Vested. To buy CANC from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Tema Oncology ETF (CANC) on Vested. You can start investing in Tema Oncology ETF (CANC) with a minimum investment of $1.
The 52-week high price of Tema Oncology ETF (CANC) is $39.95. The 52-week low price of Tema Oncology ETF (CANC) is $23.48.
The stock symbol (or ticker) of Tema Oncology ETF is CANC.
Yes, you can setup SIP in Tema Oncology ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of CANC on the Vested app.
The expense ratio of Tema Oncology ETF (CANC) is 0.75%.
Link copied 
